Atlas FDA

GORE CARDIOFORM Septal Occluder (GSO)

FDA premarket approval P050006/S077 · decided 2019-09-17

Approval details

PMA number
P050006
Supplement
S077
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
GORE CARDIOFORM Septal Occluder (GSO)
Generic name
Transcatheter septal occluder
Applicant
W. L. Gore & Associates, Inc.
Date received
2019-06-03
Decision date
2019-09-17
Days to decision
106 days
Decision code
APPR
Product code
MLV
Advisory committee
Cardiovascular
Expedited review
No
Location
Phonix, AZ
Statement
Approval for minor changes to the PAS Protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GORE® Tri-Lobe Balloon Catheter (K250410)W. L. Gore & Associates, Inc.2025-06-02
GORE® PROPATEN® Vascular Graft (K240083)W. L. Gore & Associates, Inc.2024-03-01
GORE® PROPATEN® Vascular Graft (K232312)W. L. Gore & Associates, Inc.2024-01-09
GORE® ACUSEAL Vascular Graft (K233551)W. L. Gore & Associates, Inc.2023-12-19
GORE® ACUSEAL Vascular Graft (K231505)W. L. Gore & Associates, Inc.2023-06-23
GORE BIO-A Tissue Reinforcement (K191773)W. L. Gore & Associates, Inc.2019-07-31
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement (K181940)W. L. Gore & Associates, Inc.2018-08-17
GORE ENFORM Biomaterial (K173333)W. L. Gore & Associates, Inc.2018-04-05